MiR-29b Inhibits Ventricular Remodeling By Activating Notch Signaling Pathway in the Rat Myocardial Infarction Model
DOI:
https://doi.org/10.1532/hsf.2079Abstract
Background: To study the effect of miR-29b on myocardial infarction via Notch signaling pathway in rats.
Methods: The rat acute myocardial infarction (AMI) models were established and were divided into AMI group, sham group and normal group (N = 10 in each group). HE (Hemotoxylin and eosin) staining was used to detect whether the model was constructed successfully. MiR-29b mimics, inhibitors, mimics negative control (NC) were transfected into H9c2 (2-1) cells. Then, cells were divided into a mimics group, inhibitor group, NC group, and blank group. The relative expression levels of miR-29b, Notch1, DII4 and Hesl were detected by qRT-PCR. The expression of NICD1 was detected by Western blotting.
Results: The rat AMI model was successfully constructed. Compared with normal and sham groups, the miR-29b expression was down-regulated, while the expression of Notch1, DII4 and Hesl was increased, and the NICD1 protein expression was increased in the myocardial infarction area of the AMI group (P < .05). Compared with the NC and blank groups, the relative expression of Notch1, DII4, Hesl and NICD1 were upregulated in the mimics group (P < .05), whereas the expression of Notch1, DII4, Hesl and NICD1 in the inhibitor group was decreased (P < .05).
Conclusion: MiR-29b inhibited myocardial fibrosis and cardiac hypertrophy by activating the Notch signaling pathway and protected myocardium against myocardial infarction.
References
Chen L, Anjak A, Zhou M, et al. 2010. Abstract 21055: Direct Nicd1 Overexpression Enhances Cardiac Commitment of Cpcs and Improve Heart Repair After Acute Myocardial Infarction via Notch1/gata4 Signaling. Circulation 122:A21055.
Chen X, Xiao W, Chen W, et al. 2017. MicroRNA-26a and -26b inhibit lens fibrosis and cataract by negatively regulating Jagged-1/Notch signaling pathway. Cell Death & Differentiation 24:1431.
Croquelois A, Domenighetti AA, Nemir M, et al. 2008. Control of the adaptive response of the heart to stress via the Notch1 receptor pathway. Journal of Experimental Medicine 205:3173-85.
E vR, LB S, JE T, et al. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences of the United States of America 105:13027-32.
Fan YH, Dong H, Pan Q, et al. 2011. Notch signaling may negatively regulate neonatal rat cardiac fibroblast-myofibroblast transformation. Physiological Research 60:739-48.
Gopalakrishnan N, Sivasithamparam ND, Devaraj H. 2014. Synergistic association of Notch and NFκB signaling and role of Notch signaling in modulating epithelial to mesenchymal transition in colorectal adenocarcinoma. Biochimie 107:310-8.
Gude NA, Emmanuel G, Wu W, et al. 2008. Activation of Notch-mediated protective signaling in the myocardium. Circulation Research 102:1025-35.
Jin JL, Deng ZT, Lyu RG, et al. 2017. [Expression changes of Notch and nuclear factor-κB signaling pathways in the rat heart with myocardial infarction]. China Medical Abstracts (Internal Medicine) 45:507-12.
Lew WY, Bayna E, Dalle ME, et al. 2014. Myocardial fibrosis induced by exposure to subclinical lipopolysaccharide is associated with decreased miR-29c and enhanced NOX2 expression in mice. Plos One 9:e107556.
Li Y, Hiroi Y, Liao JK. 2010. Notch Signaling as an Important Mediator of Cardiac Repair and Regeneration After Myocardial Infarction. Trends in Cardiovascular Medicine 20:228-31.
Li Y, Hiroi Y, Ngoy S, et al. 2011. Notch1 in Bone Marrow-derived Cells Mediates Cardiac Repair Following Myocardial Infarction. Circulation 123:866.
Lin QX, Yong-Heng FU, Huang H, et al. 2012. miR-29b mediates effect of carvedilol on inhibition of acute myocardium infarction-induced myocardial fibrosis. Chinese Journal of Pathology Physiology.
Melchiorbecker A, Dai G, Ding Z, et al. 2011. Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast Phenotype. Journal of Biological Chemistry 286:17365-75.
Nistri S, Sassoli C, Bani D. 2017. Notch Signaling in Ischemic Damage and Fibrosis: Evidence and Clues from the Heart. Frontiers in Pharmacology 8.
Pei H, Du J, Song X, et al. 2016. Melatonin prevents adverse myocardial infarction remodeling via Notch1/Mfn2 pathway. Free Radical Biology & Medicine 97:408-17.
Qi H, Liu Y, Li S, et al. 2017. Activation of AMPK Attenuated Cardiac Fibrosis by Inhibiting CDK2 via p21/p27 and miR-29 Family Pathways in Rats. Molecular Therapy Nucleic Acids 8:277-90.
Smrčka M, Šána J, Fadrus P, et al. 2016. Global microRNA Expression Analysis of Sox-2 positive andNegative Glioblastoma Cells. 76:1959-.
Wang Z, Dong Y, Lan Y. 2016. Dose response of spironolactone improved ventricular remodeling after acute myocardial infarction. Journal of Cardiovascular & Pulmonary Diseases.
Wu F, Yu B, Zhang X, et al. 2017. Cardioprotective effect of Notch signaling on the development of myocardial infarction complicated by diabetes mellitus. Experimental & Therapeutic Medicine 14:3447.
Yanbing LI, Qiang LI, Guan X, et al. 2016. Analysis of acute myocardial infarction caused by coronary artery occlusion. Journal of Clinical Cardiology.
Yang F, Li P, Li H, et al. 2015. microRNA-29b Mediates the Antifibrotic Effect of Tanshinone IIA in Postinfarct Cardiac Remodeling. J Cardiovasc Pharmacol 65:456-64.
Zhang Y, Kanter EM, Yamada KA. 2010. Remodeling of Cardiac Fibroblasts Following Myocardial Infarction Results in Increased Gap Junction Intercellular Communication. Cardiovascular Pathology the Official Journal of the Society for Cardiovascular Pathology 19:e233.
Zhang Y, Huang X, Wei L, et al. 2014. miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-|[beta]|/Smad3 signaling. Molecular Therapy the Journal of the American Society of Gene Therapy 22:974-85.
Zhao S, Xiao X, Sun S, et al. 2018. MicroRNA-30d/JAG1 axis modulates pulmonary fibrosis through Notch signaling pathway. Pathology - Research and Practice.
Zhou X, Chen X, Cai JJ, et al. 2015. Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway. 9:4599-611.
